Friday, February 08, 2008

Genaera Corporation Presents Promising Preclinical Type 2 Diabetes Data For Trodusquemine (MSI-1436) At Keystone Symposia

By the way, weight loss offers virtually guaranteed relief, frequently called "cure."
"Genaera research scientists concluded that treatment with MSI-1436 leads to marked improvement in glucose tolerance and lowers plasma insulin levels in diet-induced obese (DIO) mice and improves fasting blood glucose and glucose tolerance in hyperglycemic animal models, and that these effects are maintained over time."
But why would you want cheaper, faster, better when you can have drugs?

Keep listening to the experts if drugs are your preference.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.